# Varenicline for Smoking Cessation in Hospitalized Patients With Psychiatric Disorders

> **NCT03809897** · PHASE4 · WITHDRAWN · sponsor: **Hospital Universitari Vall d'Hebron Research Institute**

## Conditions studied

- Tobacco Use Cessation
- Psychiatric Disorders

## Interventions

- **DRUG:** Varenicline
- **DRUG:** Nicotine patch

## Key facts

- **NCT ID:** NCT03809897
- **Lead sponsor:** Hospital Universitari Vall d'Hebron Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-01
- **Primary completion:** 2020-04
- **Final completion:** 2020-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Budget not sufficient to cover the study scope proposed and recruitment rates expected to be no sufficient.
- **Last updated:** 2019-03-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03809897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03809897, "Varenicline for Smoking Cessation in Hospitalized Patients With Psychiatric Disorders". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03809897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*